Efficacy of rivastigmine in comparison to ginkgo for treating Alzheimer's dementia

To assess the efficacy of the Ginkgo biloba in patients with dementia of the Alzheimer type in slowing down the disease's degenerative progression and the patients' cognitive impairment compared with rivastigmine. Total 56 patients aged 50-75 years, suffering from dementia, were allocated...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the Pakistan Medical Association 2012-07, Vol.62 (7), p.677-680
Main Authors: Nasab, Nastaran Majdi, Bahrammi, Mohammad Ali, Nikpour, Mohammad Reza Amiri, Rahim, Fakher, Naghibis, Sayed Navid
Format: Article
Language:English
Subjects:
Aged
Alzheimer Disease - drug therapy
Alzheimer's disease
Analysis of Variance
Care and treatment
Cholinesterase Inhibitors - therapeutic use
Comparative analysis
Development and progression
Diagnosis
Disease Progression
Double-Blind Method
Drug therapy
Female
Ginkgo
Ginkgo biloba
Health aspects
Humans
Male
Middle Aged
Phenylcarbamates - therapeutic use
Phytotherapy
Rivastigmine
Treatment Outcome
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To assess the efficacy of the Ginkgo biloba in patients with dementia of the Alzheimer type in slowing down the disease's degenerative progression and the patients' cognitive impairment compared with rivastigmine. Total 56 patients aged 50-75 years, suffering from dementia, were allocated into one of the two treatments: group 1) Ginkgo biloba (120 mg daily dose); group 2) rivastigmine (4.5 mg daily dose) in a 24-week randomized double blind study. The degree of severity of dementia was assessed by the Seven Minute test and the Mini-Mental State Examination. Our results confirm the clinical efficacy of rivastigmine in the dementia of the Alzheimer type, comparing to Ginkgo biloba. There are few published trials that have directly compared a cholinesterase inhibitor with Ginkgo for dementia. This study directly compares a cholinesterase inhibitor with Ginkgo biloba for dementia of the Alzheimer type. Our study suggests that there are differences in the efficacy of Ginkgo biloba and rivastigmine in the treatment of Alzheimer's dementia. In addition, this study suggested that cholinesterase inhibitors should be used in preference to Ginkgo biloba in patients with mild to moderate AD.
ISSN:0030-9982